These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 388905

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Influenza vaccination. The importance of antigen amount and adjuvant with reference to the humoral antibody formation after influenza vaccination. A comparative double-blind study with various vaccines].
    Sarateanu DE, Ehrengut W.
    Fortschr Med; 1981 Sep 10; 99(34):1348-52. PubMed ID: 7026399
    [No Abstract] [Full Text] [Related]

  • 24. Leukemia virus-induced immunosuppression. IX. Depression of delayed hypersensitivity and MIF production after infection of mice with Friend leukemia virus.
    Mortensen RF, Ceglowski WS, Friedman H.
    J Immunol; 1973 Dec 10; 111(6):1810-9. PubMed ID: 4584404
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Antibody formation and preservation against the envelope antigens of influenza virus subtype A(H3N2) after infection and vaccination].
    Stumpa A, Tůmová B.
    Tr Inst Im Pastera; 1982 Dec 10; 59():23-8. PubMed ID: 6764986
    [No Abstract] [Full Text] [Related]

  • 28. [Cellular immunity mediators in viral diseases (a review of the foreign literature)].
    Shepel' NG.
    Veterinariia; 1978 Mar 10; (3):109-13. PubMed ID: 347691
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Effectiveness of inactivated vaccines against influenza].
    Fridman EA, Peradze TV.
    Tr Inst Im Pastera; 1982 Mar 10; 58():84-94. PubMed ID: 6764983
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Influenza and influenza immunization.
    Fulginiti VA.
    Ariz Med; 1976 Dec 10; 33(12):999-1006. PubMed ID: 797353
    [No Abstract] [Full Text] [Related]

  • 35. A single intranasal immunization with inactivated influenza virus and alpha-galactosylceramide induces long-term protective immunity without redirecting antigen to the central nervous system.
    Youn HJ, Ko SY, Lee KA, Ko HJ, Lee YS, Fujihashi K, Boyaka PN, Kim SH, Horimoto T, Kweon MN, Kang CY.
    Vaccine; 2007 Jul 09; 25(28):5189-98. PubMed ID: 17548137
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. T-cell-dependent reactivity against tumor-associated antigens on allogeneic target cells.
    Holden HT, Landolfo S, Herberman RB.
    Transplant Proc; 1977 Mar 09; 9(1):1149-52. PubMed ID: 194368
    [No Abstract] [Full Text] [Related]

  • 38. Cytotoxic T cells kill influenza virus infected cells but do not distinguish between serologically distinct type A viruses.
    Zweerink HJ, Courtneidge SA, Skehel JJ, Crumpton MJ, Askonas BA.
    Nature; 1977 May 26; 267(5609):354-6. PubMed ID: 194164
    [No Abstract] [Full Text] [Related]

  • 39. Influenza vaccination for terminally ill cancer patients receiving palliative care: a preliminary report.
    Sasson M, Mandelboim M, Shvartzman P.
    J Pain Symptom Manage; 2011 Feb 26; 41(2):485-90. PubMed ID: 21145200
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.